ROCK
ROCK (Rho-associated protein kinase) is a kinase belonging to the AGC family of serine-threonine kinases and takes part in regulating the shape and movement of cells by acting on the cytoskeleton.
Products Related to ROCK(72)
- GC50043SR 3677 dihydrochlorideCAS: 1781628-88-3Purity: >98%
Potent, selective Rho-kinase (ROCK) inhibitor
- GC50092RKI 1447 dihydrochlorideCAS: 1782109-09-4Purity: >98.00%
Potent and selective ROCK inhibitor; antitumor
- GC63716Sovesudil hydrochlorideCAS: 2984963-50-8Purity: >98%
Sovesudil (PHP-201) hydrochloride is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively.
- GC66050Rho-Kinase-IN-2CAS: 2573071-18-6Purity: >98%
Rho-Kinase-IN-2 (Compound 23) is an orally active, selective, and central nervous system (CNS)-penetrant Rho Kinase (ROCK) inhibitor (ROCK2 IC50=3 nM). Rho-Kinase-IN-2 can be used in Huntington's research.
- GC66338ROCK1-IN-1CAS: 692869-38-8Purity: >99.50%
ROCK1-IN-1 is a ROCK1 inhibitor with a Ki value of 540 nM. ROCK1-IN-1 can be used for the research of hypertension, glaucoma and erectile dysfunction.
- GC69776PT-262CAS: 86811-36-1Purity: >99.00%
PT-262 is an effective ROCK inhibitor with an IC50 value of approximately 5 μM. PT-262 induces loss of mitochondrial membrane potential and increases activation of caspase-3 and cell apoptosis. PT-262 inhibits phosphorylation of ERK and CDC2 through a p53-independent pathway. PT-262 blocks cellular cytoskeleton function and cell migration. PT-262 has anti-cancer activity.
- GC70451Rho-Kinase-IN-3CAS: 864082-23-5
Rho-Kinase-IN-3 (compound 12) is a potent and selective Rho kinase (ROCK1) inhibitor with an IC50 value of 8 nM.
- GC71281Chroman 1 dihydrochloridePurity: >99.00%
Chroman 1 dihydrochloride is a highly potent and selective ROCK inhibitor.
- GC71389ROCK2-IN-6 hydrochlorideCAS: 2762238-94-6Purity: >99.00%
ROCK2-IN-6 hydrochloride (Comp A) is a selective ROCK2 inhibitor, can be used for ROCK mediated diseases, autoimmune diseases and inflammation research.
- GC72976Rhodblock 6CAS: 886625-06-5Purity: >98.00%
Rhodblock 6 is a Rho kinase (ROCK) inhibitor that inhibits phospho-MRLC (myosin regulatory light chain) localization.
- GC79115ROCK2-IN-12CAS: 3086603-12-2Purity: >98.00%
ROCK2-IN-12 (Compound A25) is a selective ROCK2 inhibitor with an IC 50 of 7.0 nM for ROCK2 over ROCK1.
- GC79116NRL-1049 dihydrochlorideCAS: 1973494-17-5Purity: >99.00%
NRL-1049 dihydrochloride (BA-1049) is a selective and orally active rho-associated protein kinase 2 ( ROCK2 ) inhibitor with an IC 50 of 0.59 μM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC50043 | SR 3677 dihydrochloride | 1781628-88-3 | >98% | |
Potent, selective Rho-kinase (ROCK) inhibitor | ||||
| GC50092 | RKI 1447 dihydrochloride | 1782109-09-4 | >98.00% | |
Potent and selective ROCK inhibitor; antitumor | ||||
| GC50116 | OXA 06 dihydrochloride | 1825455-91-1 | >98% | |
Potent ROCK inhibitor | ||||
| GC63253 | Verosudil | 1414854-42-4 | >99.50% | |
Verosudil (AR-12286) is a potent, selective Rho-kinase (ROCK) inhibitor with Kis of 2 and 2 nM for ROCK1 and ROCK2, respectively. | ||||
| GC63333 | Cotosudil | 1258833-31-6 | >99.00% | |
| GC63351 | Sovesudil | 1333400-14-8 | >98.00% | |
Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively. | ||||
| GC63716 | Sovesudil hydrochloride | 2984963-50-8 | >98% | |
Sovesudil (PHP-201) hydrochloride is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively. | ||||
| GC66050 | Rho-Kinase-IN-2 | 2573071-18-6 | >98% | |
Rho-Kinase-IN-2 (Compound 23) is an orally active, selective, and central nervous system (CNS)-penetrant Rho Kinase (ROCK) inhibitor (ROCK2 IC50=3 nM). Rho-Kinase-IN-2 can be used in Huntington's research. | ||||
| GC66338 | ROCK1-IN-1 | 692869-38-8 | >99.50% | |
ROCK1-IN-1 is a ROCK1 inhibitor with a Ki value of 540 nM. ROCK1-IN-1 can be used for the research of hypertension, glaucoma and erectile dysfunction. | ||||
| GC69776 | PT-262 | 86811-36-1 | >99.00% | |
PT-262 is an effective ROCK inhibitor with an IC50 value of approximately 5 μM. PT-262 induces loss of mitochondrial membrane potential and increases activation of caspase-3 and cell apoptosis. PT-262 inhibits phosphorylation of ERK and CDC2 through a p53-independent pathway. PT-262 blocks cellular cytoskeleton function and cell migration. PT-262 has anti-cancer activity. | ||||
| GC70451 | Rho-Kinase-IN-3 | 864082-23-5 | - | |
Rho-Kinase-IN-3 (compound 12) is a potent and selective Rho kinase (ROCK1) inhibitor with an IC50 value of 8 nM. | ||||
| GC70857 | LIMK-IN-1 | 1116571-01-7 | - | |
LIMK-IN-1 (Compound 14) is an inhibitor of LIM-Kinase (LIMK), with IC50s of 0.5 nM and 0.9 nM for LIMK1 and LIMK2, respectively. | ||||
| GC71056 | Zelasudil | 2365193-22-0 | >99.00% | |
Zelasudil is a Rho-associated (ROCK) kinase inhibitor. | ||||
| GC71281 | Chroman 1 dihydrochloride | - | >99.00% | |
Chroman 1 dihydrochloride is a highly potent and selective ROCK inhibitor. | ||||
| GC71389 | ROCK2-IN-6 hydrochloride | 2762238-94-6 | >99.00% | |
ROCK2-IN-6 hydrochloride (Comp A) is a selective ROCK2 inhibitor, can be used for ROCK mediated diseases, autoimmune diseases and inflammation research. | ||||
| GC72959 | DJ4 | 1681020-24-5 | >98.00% | |
DJ4 is a ATP-competitive inhibitor of ROCK1/2 (IC50 values:5 and 50 nM) and MRCKα/β (IC50 values:10 and 100 nM). | ||||
| GC72976 | Rhodblock 6 | 886625-06-5 | >98.00% | |
Rhodblock 6 is a Rho kinase (ROCK) inhibitor that inhibits phospho-MRLC (myosin regulatory light chain) localization. | ||||
| GC73226 | THK01 | 2226941-26-8 | >99.00% | |
THK01 is a potent ROCK2 inhibitor with IC50 values of 5.7 and 923 nM for ROCK2 and ROCK1, respectively. | ||||
| GC79115 | ROCK2-IN-12 | 3086603-12-2 | >98.00% | |
ROCK2-IN-12 (Compound A25) is a selective ROCK2 inhibitor with an IC 50 of 7.0 nM for ROCK2 over ROCK1. | ||||
| GC79116 | NRL-1049 dihydrochloride | 1973494-17-5 | >99.00% | |
NRL-1049 dihydrochloride (BA-1049) is a selective and orally active rho-associated protein kinase 2 ( ROCK2 ) inhibitor with an IC 50 of 0.59 μM. | ||||
| GC13423 | Y-39983 dihydrochloride | 173897-44-4 | >98.50% | |
ROCK family inhibitor | ||||
| GC15712 | Y-27632 | 146986-50-7 | >98.00% | |
A ROCK inhibitor,potent and selective | ||||
| GC10722 | SR-3677 | 1072959-67-1 | >99.50% | |
Rho Kinase (ROCK-II) inhibitor | ||||
| GC13869 | Fasudil | 103745-39-7 | >98.00% | |
Fasudil (HA-1077; AT877) is a non-specific RhoA/ROCK inhibitor with a K i of 0.33μM and an IC 50 of 0.158μM for ROCK1, and IC 50 of 4.58μM, 12.30μM, and 1.650μM for ROCK2, PKA, PKC, and PKG, respectively. | ||||
